Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS.

Saved in:
Bibliographic Details
Title: Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS.
Authors: Rademaker E; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. e.rademaker-2@umcutrecht.nl.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands. e.rademaker-2@umcutrecht.nl., Filippini DFL; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Haitsma Mulier JLG; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands., Slim MA; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Amstel RBE; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bhavani SV; Department of Medicine, Emory University, Atlanta, Georgia., Juffermans NP; Laboratory of Translational Intensive Care, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Intensive Care, Erasmus Medical Center, Rotterdam, The Netherlands., de Grooth HS; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Derde LPG; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands., Cremer OL; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Bos LDJ; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands.
Corporate Authors: Amsterdam U. M. C. COVID-19 Biobank Study Group
Source: Intensive care medicine experimental [Intensive Care Med Exp] 2025 Jul 09; Vol. 13 (1), pp. 70. Date of Electronic Publication: 2025 Jul 09.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag, GmbH Country of Publication: Germany NLM ID: 101645149 Publication Model: Electronic Cited Medium: Print ISSN: 2197-425X (Print) Linking ISSN: 2197425X NLM ISO Abbreviation: Intensive Care Med Exp Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40632330
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rademaker+E%22">Rademaker E</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. e.rademaker-2@umcutrecht.nl.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands. e.rademaker-2@umcutrecht.nl.<br /><searchLink fieldCode="AU" term="%22Filippini+DFL%22">Filippini DFL</searchLink>; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Haitsma+Mulier+JLG%22">Haitsma Mulier JLG</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Slim+MA%22">Slim MA</searchLink>; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Amstel+RBE%22">van Amstel RBE</searchLink>; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bhavani+SV%22">Bhavani SV</searchLink>; Department of Medicine, Emory University, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Juffermans+NP%22">Juffermans NP</searchLink>; Laboratory of Translational Intensive Care, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Department of Intensive Care, Erasmus Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Grooth+HS%22">de Grooth HS</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Derde+LPG%22">Derde LPG</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, Utrecht University, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cremer+OL%22">Cremer OL</searchLink>; Department of Intensive Care Medicine, UMC Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bos+LDJ%22">Bos LDJ</searchLink>; Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Pulmonology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), University of Amsterdam, Amsterdam, The Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Amsterdam+U%2E+M%2E+C%2E+COVID-19+Biobank+Study+Group%22">Amsterdam U. M. C. COVID-19 Biobank Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101645149%22">Intensive care medicine experimental</searchLink> [Intensive Care Med Exp] 2025 Jul 09; Vol. 13 (1), pp. 70. <i>Date of Electronic Publication: </i>2025 Jul 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%2C+GmbH%22">Springer-Verlag, GmbH </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101645149 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2197-425X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222197425X%22">2197425X </searchLink><i>NLM ISO Abbreviation: </i>Intensive Care Med Exp <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40632330
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s40635-025-00779-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 70
    Titles:
      – TitleFull: Immunobiological effects of tocilizumab across respiratory subphenotypes in COVID-19 ARDS.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rademaker E
      – PersonEntity:
          Name:
            NameFull: Filippini DFL
      – PersonEntity:
          Name:
            NameFull: Haitsma Mulier JLG
      – PersonEntity:
          Name:
            NameFull: Slim MA
      – PersonEntity:
          Name:
            NameFull: van Amstel RBE
      – PersonEntity:
          Name:
            NameFull: Bhavani SV
      – PersonEntity:
          Name:
            NameFull: Juffermans NP
      – PersonEntity:
          Name:
            NameFull: de Grooth HS
      – PersonEntity:
          Name:
            NameFull: Derde LPG
      – PersonEntity:
          Name:
            NameFull: Cremer OL
      – PersonEntity:
          Name:
            NameFull: Bos LDJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 07
              Text: 2025 Jul 09
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2197-425X
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Intensive care medicine experimental
              Type: main
ResultId 1